Tejnaksh Healthcare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Tejnaksh Healthcare Ltd. on BSE

Load latest

Tejnaksh Healthcare Ltd.

23 May 2025

18.50

-0.27%

Board Meeting

Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Audited Result And Any Other Matter …

BSE India

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1.Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2025; 2. Any other matter with the permission of the Chair

pdf

Tejnaksh Healthcare Ltd.

19 May 2025

18.50

-0.27%

Company Update

Tejnaksh Healthcare Ltd - 539428 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Please refer letter in relation to reappointment of Managing Director-Dr Ashish Rawandale.

pdf

Tejnaksh Healthcare Ltd.

28 Apr 2025

18.50

-0.27%

Corp. Note

Tejnaksh Healthcare Ltd - 539428 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Tejnaksh Healthcare Ltd 2 CIN NO. L85100MH2008PLC179034 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2023-24,2024-25 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2023-24,FY 2022-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Afrin ShaikhDesignation :-Company Secretary Name of the Chief Financial Officer :- Ramesh Kuwar Designation : -CFO Date: 28/04/2025

pdf

Tejnaksh Healthcare Ltd.

28 Apr 2025

18.50

-0.27%

Corp. Note

Tejnaksh Healthcare Ltd - 539428 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTejnaksh Healthcare Ltd 2CIN NO.L85100MH2008PLC179034 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1.05 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Afrin Shaikh Designation: Company Secretary EmailId: cs.tejnaksh@gmail.com Name of the Chief Financial Officer: Ramesh Kuwar Designation: CFO EmailId: rdk.1963@rediffmail.com Date: 28/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Tejnaksh Healthcare Ltd.

23 Apr 2025

18.50

-0.27%

Company Update

Tejnaksh Healthcare Ltd - 539428 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please Find Attached certificate received from Cameo Corporate Services limited (RTA) as on 31st March 2025.

pdf

Tejnaksh Healthcare Ltd.

15 Apr 2025

18.50

-0.27%

Company Update

Tejnaksh Healthcare Ltd - 539428 - Board Meeting Outcome for In Continuation Of Our Intimation For …

BSE India

In continuation of our intimation for outcome of the meeting dated 15/04/2025, we are submitting a draft letter of offer upto Rs. 725 lakhs approved by the Board of directors of the company at their meeting held today." Please find the attached draft letter.

pdf

Tejnaksh Healthcare Ltd.

15 Apr 2025

18.50

-0.27%

Board Meeting

Tejnaksh Healthcare Ltd - 539428 - Board Meeting Outcome for Outcome Under Regulation 30 Of SEBI …

BSE India

In continuation of earlier intimation dated April 9, 2025, in compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it was informed that the Meeting of the Board of Directors of the company is scheduled to be held on Tuesday, April 15, 2025 to discuss, inter alia, the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company, we have to inform that the Board after careful consideration of the draft letter offer for the proposed rights issue upto Rs. 725 lakhs and matters incidental or consequential thereto, approved the draft letter and authorized its filing on-line with BSE for their approval, the designated Stock Exchange as per applicable provisions of SEBI ICDR, 2018.

pdf

Tejnaksh Healthcare Ltd.

12 Apr 2025

18.50

-0.27%

Company Update

Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Reschedule Of Meeting Of The Board …

BSE India

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2025 ,inter alia, to consider and approve We wish to inform you that the Meeting of the Board of Directors of the company was schedule to be held on Saturday, April 12, 2025 postponed to Tuesday, 15th April 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company.

pdf

Tejnaksh Healthcare Ltd.

07 Apr 2025

18.50

-0.27%

Board Meeting

Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI …

BSE India

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and approve In compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the company is scheduled to be held on Saturday, April 12, 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. 2. To Consider Change in Registered o??ice of the company within the local limits of same Town & City. 3. Any other matter with permission of Chairman of the meeting.

pdf

Tejnaksh Healthcare Ltd.

25 Mar 2025

18.50

-0.27%

SAST

Tejnaksh Healthcare Ltd - 539428 - Closure of Trading Window

BSE India

Kindly Refer the announcement relating to closure of the trading window in the letter attached

pdf

Is Tejnaksh Healthcare Ltd. worth buying?

22 Votes:

Buy 77.27%

Sell 13.64%

Hold 9.09%